Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

RAPT Therapeutics Stock News

RAPTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.8786

0.004200.48%

At close: -

$0.8775

-0.00110-0.13%

After Hours: Apr 25, 6:24 PM EDT

RAPT Therapeutics (RAPT) Forecast

News

Earnings RAPT Therapeutics (RAPT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest RAPT Therapeutics Stock News | NASDAQ:RAPT | Benzinga

Get the latest news on RAPT Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on RAPT Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, March 10, 2025

HC Wainwright & Co. Reiterates Buy on RAPT Th...
Benzinga Newsdesk - Mar 10, 2025, 7:44AM

Thursday, March 06, 2025

RAPT Therapeutics Q4 EPS $(1.14) Misses $(0.3...
Benzinga Newsdesk - Mar 6, 2025, 8:42AM

Monday, January 06, 2025

RAPT Therapeutics Appoints Lori Lyons-William...
Benzinga Newsdesk - Jan 6, 2025, 8:07AM

Thursday, December 26, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Dec 26, 2024, 4:05PM
This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday
Avi Kapoor - Dec 26, 2024, 9:37AM
HC Wainwright & Co. Upgrades RAPT Therapeutic...
Benzinga Newsdesk - Dec 26, 2024, 6:17AM

Monday, December 23, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Dec 23, 2024, 4:07PM
Why RAPT Therapeutics Stock Gained Over 100% On Monday?
Lekha Gupta - Dec 23, 2024, 1:00PM
US Stocks Mixed, Dow Tumbles 150 Points
Avi Kapoor - Dec 23, 2024, 10:00AM
RAPT Therapeutics shares are trading higher a...
Benzinga Newsdesk - Dec 23, 2024, 8:52AM
Market-Moving News for December 23rd
Benzinga Newsdesk - Dec 23, 2024, 7:38AM
RAPT Therapeutics To Raise $150M in Private P...
Benzinga Newsdesk - Dec 23, 2024, 7:13AM
RAPT Therapeutics Secures Global Rights to De...
Benzinga Newsdesk - Dec 23, 2024, 7:01AM

Monday, November 25, 2024

HC Wainwright & Co. Reiterates Neutral on RAP...
Benzinga Newsdesk - Nov 25, 2024, 8:14AM

Tuesday, November 12, 2024

Wells Fargo Maintains Overweight on RAPT Ther...
Benzinga Newsdesk - Nov 12, 2024, 9:39AM
RAPT Therapeutics Q3 EPS $(0.47) Beats $(0.54...
Benzinga Newsdesk - Nov 12, 2024, 8:14AM
HC Wainwright & Co. Reiterates Neutral on RAP...
Benzinga Newsdesk - Nov 12, 2024, 6:39AM

Monday, November 11, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Nov 11, 2024, 4:09PM
Crude Oil Down 3%; Aramark Posts Upbeat Earnings
Avi Kapoor - Nov 11, 2024, 2:31PM
JP Morgan Downgrades RAPT Therapeutics to Und...
Benzinga Newsdesk - Nov 11, 2024, 1:46PM
Nasdaq Moves Lower; Canaan Shares Surge
Avi Kapoor - Nov 11, 2024, 1:19PM
Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury
Vandana Singh - Nov 11, 2024, 10:34AM
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
Avi Kapoor - Nov 11, 2024, 9:49AM
RAPT Therapeutics shares are trading lower af...
Benzinga Newsdesk - Nov 11, 2024, 8:10AM
RAPT Therapeutics Terminates Zelnecirnon Prog...
Benzinga Newsdesk - Nov 11, 2024, 8:02AM

Wednesday, November 06, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Nov 6, 2024, 11:34AM

Monday, November 04, 2024

10 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Nov 4, 2024, 7:29AM

Wednesday, October 02, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Oct 2, 2024, 12:31PM

Monday, September 09, 2024

UBS Maintains Neutral on RAPT Therapeutics, L...
Benzinga Newsdesk - Sep 9, 2024, 10:23AM

Tuesday, August 20, 2024

HC Wainwright & Co. Reiterates Neutral on RAP...
Benzinga Newsdesk - Aug 20, 2024, 7:16AM

Thursday, August 08, 2024

RAPT Therapeutics Q2 EPS $(0.71) Beats $(0.72...
Benzinga Newsdesk - Aug 8, 2024, 8:27AM

Tuesday, July 23, 2024

HC Wainwright & Co. Reiterates Neutral on RAP...
Benzinga Newsdesk - Jul 23, 2024, 7:20AM

Monday, July 22, 2024

Rapt Therapeutics Will Reduce Its Workforce B...
Benzinga Newsdesk - Jul 22, 2024, 8:05AM

Tuesday, July 16, 2024

Lisata Stock Rallies More Than 30% YTD: Here's Why
Zacks - Jul 16, 2024, 1:38PM

Friday, July 12, 2024

Here's Why You Should Invest in Beam Therapeutics Now
Zacks - Jul 12, 2024, 11:57AM

Wednesday, July 10, 2024

Athira Completes Dosing in Alzheimer's Study, Stock Up
Zacks - Jul 10, 2024, 3:42PM

Thursday, June 27, 2024

Beam Therapeutics Begins Dosing in Phase I/II AATD Study
Zacks - Jun 27, 2024, 2:47PM

Monday, June 03, 2024

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Jun 3, 2024, 4:31PM

Tuesday, May 21, 2024

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Avi Kapoor - May 21, 2024, 8:39AM

Tuesday, May 14, 2024

Wolfe Research Downgrades RAPT Therapeutics t...
Benzinga Newsdesk - May 14, 2024, 8:01AM

Friday, May 10, 2024

Barclays Downgrades RAPT Therapeutics to Equa...
Benzinga Newsdesk - May 10, 2024, 9:21AM
Guggenheim Downgrades RAPT Therapeutics to Ne...
Benzinga Newsdesk - May 10, 2024, 6:29AM

Thursday, May 09, 2024

What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
Vandana Singh - May 9, 2024, 2:12PM
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor - May 9, 2024, 1:57PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - May 9, 2024, 12:31PM
RAPT Therapeutics shares are trading lower. T...
Benzinga Newsdesk - May 9, 2024, 11:11AM
RAPT Therapeutics Q1 EPS $(0.79) Beats $(0.81...
Benzinga Newsdesk - May 9, 2024, 9:01AM

Wednesday, April 10, 2024

HC Wainwright & Co. Reiterates Neutral on RAP...
Benzinga Newsdesk - Apr 10, 2024, 6:19AM

Tuesday, April 09, 2024

RAPT Therapeutics Highlights Results From Pha...
Benzinga Newsdesk - Apr 9, 2024, 12:01PM

Wednesday, March 27, 2024

JP Morgan Maintains Neutral on RAPT Therapeut...
Benzinga Newsdesk - Mar 27, 2024, 10:44AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved